Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

PAION reports successful meta-analysis for pain drug M6G

Nov. 4, 2008

Recent GSK, Pfizer and Roche patents disclose new antipsychotic agents

Nov. 4, 2008

FDA approves new indication for Hospira's Precedex in nonintubated patients

Nov. 3, 2008

Galapagos and CHDI sign new collaboration agreements in Huntington's disease

Nov. 3, 2008

Cipher provides update on CIP-Tramadol ER regulatory filing

Oct. 30, 2008

Recent patents divulge novel analgesic agents

Oct. 30, 2008

UCB's Vimpat approved by FDA as adjunctive therapy for seizures

Oct. 29, 2008

New agents for neuropsychiatric disorders reported in recent Actelion and Abbott patents

Oct. 29, 2008

Minster announces results from phase II trial of tonabersat for migraine with aura

Oct. 29, 2008

NeuroSearch initiates dosing in HART study of ACR-16 in Huntington's disease

Oct. 29, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...